A61L31/18

HYDROGELS FORMED IN SITU AND COMPOSITION DESIGN FOR INTRAUTERINE USE
20220143276 · 2022-05-12 ·

Medical hydrogel systems for providing improved properties for certain medical applications are described. The hydrogel systems are effective for forming a space filling hydrogel in a body cavity and for the prevention of adhesion formation between tissues within the body cavity following a surgical procedure. Hydrogel delivery systems for transcervical delivery of a premixed precursor solution and an accelerator solution are described. Methods for transcervical installation of intrauterine hydrogels with distended fill are also described. The hydrogel systems, hydrogel delivery systems, and associated methods can be useful for providing degradable hydrogel in the uterine cavity, including the cervical canal, for the prevention of adhesions following intrauterine procedures.

HYDROGELS FORMED IN SITU AND COMPOSITION DESIGN FOR INTRAUTERINE USE
20220143276 · 2022-05-12 ·

Medical hydrogel systems for providing improved properties for certain medical applications are described. The hydrogel systems are effective for forming a space filling hydrogel in a body cavity and for the prevention of adhesion formation between tissues within the body cavity following a surgical procedure. Hydrogel delivery systems for transcervical delivery of a premixed precursor solution and an accelerator solution are described. Methods for transcervical installation of intrauterine hydrogels with distended fill are also described. The hydrogel systems, hydrogel delivery systems, and associated methods can be useful for providing degradable hydrogel in the uterine cavity, including the cervical canal, for the prevention of adhesions following intrauterine procedures.

Wire-formed bio-absorbable implants and methods for assembly
11724009 · 2023-08-15 · ·

Modularizable implants and stents made with bio-absorbable metal wire alloys (‘bio-metals’, e.g. magnesium and alloys), and methods for making such implants and stents. The stents or implants may include one or more wire-formed rings or comprise inter-connected cells that form nets that may serve as modules that are assembled mechanically into stents, without the need for certain manufacturing processes that may affect the durability and physical properties thereof. The wires may be formed into rings mechanically and held in place using joining cuffs, and/or adjacent wires may be secured to one other mechanically using joining cuffs to form nets which can be used as implants or formed into stents. The stents can include radiopaque portions, e.g. associated with one or more joining cuffs, to aid in the positioning and evaluation of stents in the body by serving as visual indicators of alignment and expansion that can be detected using X-rays.

3D-PRINTED BIORESORBABLE ALL-POLYMER COMPOSITE SOFT TISSUE SCAFFOLDS

Provided herein photo-reactive inks, thermal-curable materials and objects (e.g., medical implants, scaffolds, devices, etc.) made therefrom, and methods of preparation and use thereof.

COATED STENT

An implantable medical device may comprise an elongated tubular body having a scaffolding forming a plurality of cells. A polymeric covering may be disposed over at least a portion of the stent. The covering may include a plurality of voids formed in an outer surface thereof. An extracellular matrix material coating may be disposed over the polymeric covering and within the plurality of voids.

COMPOSITE MATERIALS
20230250277 · 2023-08-10 ·

The invention relates to a composite material comprising polyaryletherketone, reinforcement fibre, and contrast agent. The reinforcement fibre is present in an amount of 52 to 58 volume % based on the total volume of the composite material.

COMPOSITE MATERIALS
20230250277 · 2023-08-10 ·

The invention relates to a composite material comprising polyaryletherketone, reinforcement fibre, and contrast agent. The reinforcement fibre is present in an amount of 52 to 58 volume % based on the total volume of the composite material.

Stent assembly for use in treating bifurcation lesions and methods of making and using the same
11318030 · 2022-05-03 ·

The presently disclosed subject matter is directed to a dual stent assembly useful in treating one or more bifurcation lesions in a subject. The dual stent assembly includes a first stent and a second stent. The first stent comprises a body, proximal and distal ends, and a flare positioned at the proximal end. The first stent translates between a compressed configuration and a deployed configuration. The second stent is defined by a body comprising a sidewall, proximal and distal ends, and an orifice positioned on the body that extends through the sidewall. The second stent is translatable between a compressed configuration and a deployed configuration. The orifice is sized and shaped to align with the proximal end of the first stent when the second stent is deployed.

IMPLANTS AND BIODEGRADABLE TISSUE MARKERS
20220125954 · 2022-04-28 ·

Implantable materials may be used in an iatrogenic site. Applications include radioopaque materials for fiducial marking.

IMPLANTS AND BIODEGRADABLE TISSUE MARKERS
20220125954 · 2022-04-28 ·

Implantable materials may be used in an iatrogenic site. Applications include radioopaque materials for fiducial marking.